HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A soluble divalent class I MHC/IgG1 fusion protein activates CD8+ T cells in vivo.

Abstract
CD8+ T lymphocytes recognize tumor and viral antigens bound to class I major histocompatibility complexes (MHC). Tumors and viruses may evade detection by preventing antigen presentation. The present study was designed to determine whether a soluble divalent fusion protein, containing the extracellular domains of a class I MHC molecule fused to beta2-microglobulin and the constant domains of IgG1, could induce an immune response in vivo. Administration to mice of the fusion protein loaded with a tumor peptide induced peptide-specific T cell activation and retarded tumor growth. Administration of the fusion protein loaded with a glycoprotein B (gB) peptide derived from herpes simplex virus type 1 (HSV-1) induced gB-specific cytotoxic T lymphocytes and protected mice from a lethal HSV-1 challenge. These data suggest that antigen-loaded MHC/IgG fusion proteins may enhance T cell immunity in conditions where antigen presentation is altered.
AuthorsBrenna Carey, Monica DeLay, Jane E Strasser, Claudia Chalk, Kristen Dudley-McClain, Gregg N Milligan, Hermine I Brunner, Sherry Thornton, Raphael Hirsch
JournalClinical immunology (Orlando, Fla.) (Clin Immunol) Vol. 116 Issue 1 Pg. 65-76 (Jul 2005) ISSN: 1521-6616 [Print] United States
PMID15925833 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Histocompatibility Antigens Class I
  • Immunoglobulin G
  • Peptide Fragments
  • Recombinant Fusion Proteins
Topics
  • Animals
  • CD8-Positive T-Lymphocytes (immunology)
  • Female
  • Herpes Simplex (immunology, mortality)
  • Herpesvirus 1, Human (immunology)
  • Histocompatibility Antigens Class I (genetics, immunology)
  • Immunoglobulin G (genetics, immunology)
  • Lymphocyte Activation (immunology, physiology)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasms (drug therapy, immunology)
  • Peptide Fragments (immunology)
  • Recombinant Fusion Proteins (genetics, immunology, pharmacology)
  • T-Lymphocyte Subsets (immunology)
  • T-Lymphocytes, Cytotoxic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: